Abstract The comparative study of the human and chimpanzee genomes may shed light on the genetic ingredients for the evolution of the unique traits of humans. Here, we present a simple procedure to identify human-specific nonsense mutations that might have arisen since the human-chimpanzee divergence. The procedure involves collecting orthologous sequences in which a stop codon of the human sequence is aligned to a non-stop codon in the chimpanzee sequence and verifying that the latter is ancestral by finding homologs in other species without a stop codon. Using this procedure, we identify nine genes (CML2, FLJ14640, MT1L, NPPA, PDE3B, SERPINA13, TAP2, UIP1, and ZNF277) that would produce human-specific truncated proteins resulting in a loss or modification of the function. The premature terminations of CML2, MT1L, and SERPINA13 genes appear to abolish the original function of the encoded protein because the mutation removes a major part of the known active site in each case. The other six mutated genes are either known or presumed to produce functionally modified proteins. The mutations of five genes (CML2, FLJ14640, MT1L, NPPA, TAP2) are known or predicted to be polymorphic in humans. In these cases, the stop codon alleles are more prevalent than the ancestral allele, suggesting that the mutant alleles are approaching fixation since their emergence during the human evolution. The findings support the notion that functional modification or inactivation of genes by nonsense mutation is a part of the process of adaptive evolution and acquisition of species-specific features.
Introduction
Genome sequence contains a record of evolutionary history that a species has experienced. By comparing genome sequences of different species, one can detect genetic modifications that must have led to physical, physiological, and behavioral changes that are responsible for the speciation and accumulation of lineagespecific traits. The genome sequence of the modern human (Homo sapiens) contains numerous human-specific additions, deletions, alterations, and relocations of genetic materials that have been applied during the 5-7 million years since human and chimpanzee split. Such modifications can result in quantitative and spatiotemporal changes in gene expression and/or structural changes of individual proteins (Ruvolo 2004) .
It has been argued that crucial characteristics of a species develop by changes of gene expression pattern rather than by changes in individual protein sequences (Carroll 2005) . However, modifications in the coding sequences of genes are clearly important in either case. For example, higher expression levels for many genes in the human brain (Preuss et al. 2004 ) might be caused by modification of cis-regulatory elements associated with the genes but also by accelerated amino acid substitution of trans-acting factors that control the expression of the genes. Accelerated amino acid substitution of some genes has been reported to be associated with the evolution of particular human-specific traits; for example, the FOXP2 gene and the evolution of speech and language (Enard et al. 2002) , and the ASPM gene and the brain enlargement (Evans et al. 2004) . In dogs, breedspecific limb and skull morphology are believed to be associated with variations in the number of amino acid repeats in the Alx4 and the Runx2 proteins, respectively (Fondon and Garner 2004) . Comparison of 13,731 human genes with their chimpanzee orthologs reveals that many genes involved in sensory perception or immune defenses are subject to positive selection (Nielsen et al. 2005) .
Substitutions and in-frame insertions or deletions of amino acids are commonly observed between orthologous proteins in closely related species. However, frameshift mutations and nonsense mutations, which lead to inactivation or functional modification of the gene products, may also be associated with the acquisition of species-specific features. For example, the loss of the MYH16 gene function by a two nucleotide deletion was suggested to be linked with a specific change of skull shape by reducing masticatory muscle mass and allowing development of bigger brain during human evolution (Stedman et al. 2004) , although a new study suggests that the mutation occurred much earlier (Perry et al. 2005) . Likewise, the inactivation of the CMAH gene caused by the Alu-mediated exon deletion was proposed to be associated with brain expansion of human ancestors (Chou et al. 2002) . Other examples of genes the function of which has been lost in humans include FMO2, KRTHAP1, EMR4, and SIGLEC13 (Angata et al. 2004; Dolphin et al. 1998; Hamann et al. 2003; Winter et al. 2001) .
Recent progress of primate genome sequencing projects including chimpanzee (Pan troglodytes), orangutan (Pongo pygmaeus), and rhesus macaque (Macaca mulatta) together with the release of the nearly complete human genome sequence enables one to directly compare the genome sequences to find lineage-specific genetic alterations (Goodman et al. 2005 ; International Human Genome Sequencing Consortium 2004; Li and Saunders 2005; The Chimpanzee Sequencing and Analysis Consortium 2005). Previously, we reported identification of nine novel humanspecific frameshift mutations by comparing the human and the chimpanzee genome sequences (Hahn and Lee 2005) . In this report, we applied a similar technique to identify human-specific nonsense mutations that might result in generation of inactive or functionally modified proteins specifically in the human lineage. The procedure involves the collection of the last coding exons of human genes of which stop codons align with non-stop codons in the orthologous chimpanzee exons. Since the current chimpanzee genome assembly (build 1, November 13, 2003 release) has limited sequence accuracy, we assume that many of the mismatches between the two genome sequences are due to errors in the chimpanzee genome sequence. We therefore require that there be at least one known non-human/nonchimpanzee protein homolog for each case that supports the chimpanzee protein as being ancestral. Each human-specific mutation candidate is further scrutinized by comparing the human/chimpanzee sequences with the orthologous orangutan and/or rhesus macaque sequences assembled from the whole genome shotgun (WGS) trace data. Using this procedure, we identify nine highly probable human-specific nonsense mutations in the current human genome sequence (build 35). We discuss the possible functional consequence of each mutation.
Materials and methods

Sequence and alignment data source
The human mRNA to genome alignment data and the genome sequence assemblies (human, build 35; chimpanzee, build 1) were downloaded from the University of California at Santa Cruz (UCSC) web site (http:// www.genome.ucsc.edu) in July 2005. The human mRNA to human genome alignments were extracted from the tables 'hg17.RefSeqAli' and 'hg17.all_mrna.' The human mRNA to chimpanzee genome alignments were found in the tables 'panTro1.xenoRefSeqAli' and 'panTro1.xenoMrna.' The coding region coordinates were obtained from the tables 'hg17.gbCdnaInfo' and 'hg17.cds' to define the last codon of each human mRNA sequence. The non-redundant non-human vertebrate protein database was locally prepared by processing the nr (non-redundant) protein database of the National Center for Biotechnology Information (NCBI; ftp://www.ftp.ncbi.nlm.nih.gov/blast/db/FAS-TA/nr.gz).
Collection of the coding exons with the stop codon discrepancy For a systematic identification of human-specific nonsense mutations, we first collected the human/chimpanzee coding exon pairs, in each of which the human exon contained in-frame stop codon that was aligned with a non-stop codon in the chimpanzee genome sequence. The human mRNA to human genome sequence alignment and the human mRNA to chimpanzee genome sequence alignment data were obtained and filtered by using an in-house Perl program. If a sequence aligned to multiple places in a genome, only the best alignment was considered. The last codon sequence of each human mRNA sequence was examined to ensure that the coding region ended with one of the three stop codons. In order to remove redundancy, only one mRNA sequence (a RefSeq sequence when available) alignment was kept if more than one mRNA sequence were mapped to the same last codon in the human genome sequence. For each human mRNA sequence, the last codon sequences were extracted from the human and the corresponding chimpanzee genome sequences. Only the cases where the human genome sequence matched the human mRNA stop codon and the aligned chimpanzee codon sequence was not a stop codon were selected for further investigation.
Identification of the non-human/non-chimpanzee homologs In order to find the non-human/non-chimpanzee protein homolog, we generated a hypothetical chimpanzee-like mRNA sequence by replacing the stop codon of the human mRNA sequence with the corresponding codon in the aligned chimpanzee genome sequence. The resulting chimpanzee-like mRNA was re-translated using the start codon annotated in the human mRNA to produce a chimpanzee-like protein sequence. We then performed BLAST searches through a custom-built nonredundant non-human vertebrate protein database using the human and chimpanzee-like protein sequences as queries to find homologs in the third species. The BLAST outputs were parsed to obtain a hit list for each human/chimpanzee-like protein pair. The hit list was sorted by the BLAST score and the top five hits were retained. The cases were noted wherein the third species sequence had a score increase of at least 1 bit when the chimpanzee-like protein was used as the query over when the human protein was used. (This is a change from our previous study (Hahn and Lee 2005) wherein we used a minimum increase in score of 10 bits. The condition of minimal score increase was used here in order to detect mutations that occur near the C-terminus and therefore remove only a small number of amino acids.) The final candidate cases were subjected to the in-depth analysis described below.
Collection of the highly probable human-specific nonsense mutations
In order to verify and select highly reliable human-specific nonsense mutation cases, we manually inspected the final candidates obtained in the previous step. All available sequence data for human, chimpanzee, and other species were obtained by database searches using the NCBI BLAST web server (http://www.ncbi.nlm.-nih.gov/BLAST) and analyzed to verify that the nonsense mutations were human-specific. The genuine chimpanzee cDNAs were predicted from the chimpanzee genome sequence by assembling predicted exons. These latter were obtained from an alignment of the human mRNA and the chimpanzee genomic fragment using the GMAP program (Wu and Watanabe 2005) . The composite chimpanzee cDNAs were sometimes amended by using the chimpanzee virtual transcripts (Clark et al. 2003) or the whole genome shotgun (WGS) trace data obtained at the Trace Archive database (http:// www.ncbi.nlm.nih.gov/blast/mmtrace.shtml). The putative orangutan and the rhesus macaque orthologs were obtained by searching through the Trace Archive database and the matched WGS sequences were assembled by using the cap3 program (Huang and Madan 1999) . The chimpanzee, orangutan, and rhesus macaque orthologs were identified by the reciprocal best hit principle: The putative non-human ortholog sequence was aligned to the human genome by using the BLAT server (http://www.genome.ucsc.edu/cgi-bin/hgBlat); if the best hit was the same as the starting human gene, the sequence was regarded as orthologous. Multiple sequence alignment analyses were performed by using the ClustalW program (Thompson et al. 1994) . Allele frequencies for single nucleotide polymorphisms (SNPs) were obtained from the dbSNP database (http:// www.ncbi.nlm.nih.gov/projects/SNP). The dotplot was prepared using the dotter program (Sonnhammer and Durbin 1995) . The MEGA3 program was used for a phylogenetic analysis (Kumar et al. 2004) .
To be confirmed as a human-specific nonsense mutation we required that (1) the orthology of the human and the chimpanzee genes is not ambiguous (possible paralogous alignments between similar members of the gene families and pseudogene-to-authentic gene matches are excluded), (2) the nonsense mutation is in a stable exon (stop codons in retained introns or in alternative Alu exons are excluded), (3) the orthologous chimpanzee protein sequence shows a significant sequence similarity over the entire length with at least one known non-human protein homolog, and (4) the orthologous orangutan and/or rhesus macaque genes have a non-stop codon as the chimpanzee gene does at the putative human-specific nonsense mutation position.
Results
The procedure for a systematic identification of human-specific nonsense mutations
The genome-wide identification of human-specific nonsense mutations involves a series of filtering steps applied to the publicly-available human mRNA-to-human genome alignment and human mRNA-to-chimpanzee genome alignment data. Table 1 shows notable steps of the procedure and the number of data kept at each step. There were 81,849 human mRNA sequences that aligned in both the human and the chimpanzee genome sequences. When the redundancy was removed, 22,853 stop codons of the human transcripts aligned with the respective orthologous sequences in the human and chimpanzee genomes. As expected, most of these (22,317 cases) had the same stop codon sequence in both human and chimpanzee genome. There were 330 cases in which the human stop codon was aligned to a chimpanzee nonstop codon. The non-human/non-chimpanzee vertebrate protein sequence database was searched for homologs of these sequences using BLAST. Of the 261 cases where a homolog was found in the third species, 96 cases showed an increase in the BLAST score by at least 1 bit when the chimpanzee-like protein sequence was used over when the human protein sequence was used.
As the final step, we performed comprehensive indepth analysis on each candidate (see Materials and methods for detail) to identify nine human-specific nonsense mutations. These genes, and the nature of mutations for each case, are listed in Table 2 . These are distinct from the previously identified genes with a frameshift mutation. While this latter group of genes also has a premature stop codon, the stop codon sequence also exists in the corresponding chimpanzee sequence, although out of frame. These genes are, therefore, removed at step 4a (see Table 1 ) of the filtering process.
For each of the three genes, CML2, MT1L, and SERPINA13, the nonsense mutation probably leads to gene inactivation or production of a protein which lacks the original function since the protein produced would lack a major part of the active site (see below). The other six genes have the nonsense mutations near the C-termini and may encode modified but functional proteins. Analysis of all available sequence data suggests that the five genes (CML2, FLJ14640, MT1L, NPPA, TAP2) are polymorphic in humans. Sequence comparison of the region surrounding the human-specific stop codon mutation in human and orthologous sequences from chimpanzee and other closely related species is presented in Fig. 1 . Sequence counts supporting the given sequence from various database sources are also provided in Fig. 1 . When the mutation is known to be polymorphic, the estimated allele frequency is also given. Detailed descriptions of each case are given below.
CML2: putative N-acetyltransferase Camello 2
A cDNA sequence (accession no. BC069564) and the genome sequence of the CML2 gene show two in-frame stop codons. Both of the human stop codons align with non-stop codons in the chimpanzee ortholog (Fig. 1a) .
Comparison of the human CML2 protein sequence with that of the yeast homolog GNA1, for which the crystal structure is known (Peneff et al. 2001) revealed that the second stop codon mutation occurred in the middle of the N-acetyltransferase catalytic domain, destroying the active site of the enzyme. Either of the two mutations will remove the active site and hence the mutant protein will lose the enzymatic function.
Sequence database search revealed a human mRNA sequence (accession no. NM_016347) that has neither of the two stop codons, suggesting that the human-specific nonsense mutation is polymorphic in human population. In fact, analysis of the available genomic sequences shows that the second stop codon position is polymorphic (see Fig. 1a ). The polymorphism at the second stop codon is also present in the dbSNP database (accession Table 1 Number of sequences at each step of the procedure for identification of human-specific nonsense mutations
Step Data count Amino acid difference: chimpanzee amino acid followed by the codon number followed by human amino acid (more than one amino acid residues in case of the polymorphism in humans); X, stop codon Chimpanzee has a species-specific nonsense mutation (R1114X). Ancestral gene would encode 1117 amino acids no. rs4852974), although the allele frequency has not been reported. The coding region of the CML2 gene shows 93% nucleotide sequence identity with the NAT8 gene encoding an N-acetyltransferase (also known as CML1 for Camello 1; accession no. NM_003960). Because the reported CML2 mRNA sequences are derived from a single exon and contain two stop codons, CML2 has been proposed to represent a processed pseudogene of NAT8 (Zhang et al. 2003) . However, CML2 and NAT8 are closely mapped in the chromosome band 2p13.1 and an examination of the dotplot (Supplementary Fig. S1 ) indicates that there is a pair of genomic duplicons of about 28 kb in length, one of which contains NAT8 and the other CML2. The CML2 gene seems to be composed of two exons as NAT8 is, although no cDNA sequence with both exons of CML2 has been reported. We collected NAT8 and CML2 orthologs from apes and monkeys to determine when the duplication occurred. The orangutan NAT8 mRNA sequence is available in Fig. 1 Summary of the humanspecific nonsense mutations. Nucleotide sequences and protein sequences surrounding the human-specific mutations of the nine genes are presented: a CML2, b FLJ14640, c MT1L, d NPPA, e PDE3B, f SERPINA13, g TAP2, h UIP1, and i ZNF277. Orthologous sequences from chimpanzee, orangutan, and rhesus macaque, and other homologous sequences are aligned. The human-specific and the ancestral stop codons are underlined. Lower case letters represent nucleotides in the 3¢-untranslated region. Sequence counts show the numbers of database entries supporting the given sequence: genomic, genomic clone including bacterial artificial clone (BAC); WGS whole genome shotgun trace, EST expressed sequence tag. A blank means either that no sequence was found or that the analysis was not done. Two codon positions are shown for the genes CML2 and UIP1. The second human sequences of the genes CML2, FLJ14640, MT1L, NPPA, and TAP2 are for the respective minor alleles. Allele frequencies obtained from the dbSNP database, when available, are given in the right-most column. A human MT1L mRNA (X97261) was reported as MT1R gene GenBank (accession no. CR859753). We successfully identified chimpanzee CML2 and NAT8, and rhesus macaque NAT8 from the genome assembly and/or WGS trace data. A phylogenetic analysis based on a multiple alignment of the CML2 and NAT8 protein sequences ( Supplementary Fig. S2 ) indicates that the duplication occurred after the ape-Old World monkey split (Supplementary Fig. S3 ). It implies that the ancestor of all extant great apes, including orangutans, gorillas, chimpanzees, as well as humans, had two copies of N-acetyltransferase 8. The exact copy number of NAT8-related genes in orangutan and gorilla is yet to be identified. It is expected that both copies are fully active in chimpanzee but one copy is inactive in some (probably most) human individuals.
The human NAT8 gene encodes a kidney-and liverspecific N-acetyltransferase (Ozaki et al. 1998) . It is proposed to be involved in drug metabolism in liver. The Xenopus camello (Xcml) protein is suggested to play some role in embryogenesis by modifying the cell surface and extracellular matrix proteins in the secretory pathway (Popsueva et al. 2001) . Given that CML2 is a recent genomic duplicate of NAT8, the two genes may share similar cis-regulatory elements and hence could exhibit a similar expression pattern. The biological significance of the inactivation of one of the two functionally redundant genes is not known.
FLJ14640: hypothetical protein FLJ14640
The human FLJ14640 gene has a human-specific nonsense mutation near the carboxyl terminus ( Fig. 1b;  Supplementary Fig. S4 ). The nonsense mutation is associated with T/C single nucleotide polymorphism in human population. The dbSNP record (accession no. rs745961) indicates that the T allele producing a stop codon is prevalent: 0.754 (T) versus 0.246 (C). The mutation removes eight amino acids from the carboxyl terminus: The ancestral allele and the chimpanzee ortholog encode 791 amino acids. The FLJ14640 protein is highly conserved across species including chicken and zebrafish. The protein is predicted to contain a coiled coil domain of about 500 amino acids in length (residues roughly from 220 to 720) and shows a sequence homology with carboxyl half of the human myosin XVIIA (MYO18A) (Supplementary Fig. S5 ). Its biological function and the phenotypic consequence of the nonsense mutation in human are unclear.
MT1L: metallothionein 1L
Metallothioneins are the heavy-metal binding proteins and function in the regulation of trace metal chemistry and in the detoxification of heavy metal ions (Vallee 1995) . At least 13 class 1 metallothionein genes are clustered in the chromosome band 16q12.2. However, four of these genes, MT1I, MT1J, MT1K, and MT1L are suggested to be non-functional due to unacceptable amino acid substitutions or nonsense mutations (Stennard et al. 1994) . We have compared the human MT1L gene with its putative ape and rhesus macaque orthologs and found that the nonsense mutation at codon 26 is human-specific (Fig. 1c) . More than 30 sequence data, including 14 WGS and 20 EST clone sequences, agree with the genome sequence. Only one mRNA sequence (accession no. X97261) which was reported as MT1R gene has a non-stop codon sequence, raising the possibility of polymorphism in humans (Lambert et al. 1996) .
We inferred possible effect on the metal binding capability of the human MT1L protein imposed by the nonsense mutation. As other metallothioneins, the chimpanzee MT1L has two cysteine-rich metal binding domains: b-(N-terminal 9 cysteines) and a-domain (Cterminal 11 cysteines) (Rigby et al. 2005) . Each of the two domains can bind to up to three and four metal ions, respectively. The conserved cysteines are critical for the metal binding ability of metallothioneins. The human-specific nonsense mutation in MT1L gene removed two cysteines from the b-domain and the whole a-domain. The mutant protein, if produced, can only bind to one instead of seven metal ions, indicating that the original function of the protein is severely damaged in humans. Pseudogenization of some members in an isogenic gene cluster is rather frequently observed (Cooper et al. 2005; Gilad et al. 2003; Hesse et al. 2004 ). The putative orangutan MT1L turns out to be truncated also due to an orangutan-specific stop codon at a position different from that in the human MT1L ( Supplementary  Fig. S6 ). Thus, the presumed functional impairment of MT1L gene appears to be not entirely specific to humans only.
NPPA: natriuretic peptide precursor A
The human NPPA gene encodes a precursor protein for the atrial natriuretic peptide (ANP) that plays a central role in the regulation of blood pressure by promoting excretion of excessive salt and water (Levin et al. 1998 ). Many sequence polymorphisms have been reported for this gene. One of them is the ''T2238C'' mutation which occurs at the first position of the codon 152 (TGA to CGA). The T allele encodes a 151 amino acid-long precursor protein for the human ANP and is known as ''normal,'' whereas the C allele is known as ''mutant'' which adds two additional arginines to the ''normal'' sequence. The reason of this designation seems to be due to the prevalence of the T allele in the contemporary human population: 0.827 (T) versus 0.173 (C) (dbSNP accession no. rs5065). However, sequence comparison between the human NPPA and its orthologs from other animals including chimpanzee, orangutan, rhesus macaque, mouse, rat, cat, horse, and cow reveals that the C allele is the ancestral allele ( Fig. 1d ; Supplementary Fig. S7 ). In humans, the ancestral CGA allele has been reported to be significantly associated with increased risk of stroke recurrence (Rubattu et al. 2004 ). The derived TGA allele, which produces a peptide hormone that lacks two highly conserved C-terminal arginines, might be advantageous over the ancestral allele CGA in response to some unknown change in systemic salt physiology in humans.
PDE3B: phosphodiesterase 3B, cGMP-inhibited
The human PDE3B gene encodes a cGMP-inhibited cyclic nucleotide phosphodiesterase that modulates cyclic nucleotide signaling in adipose tissue (Miki et al. 1996) . Human PDE3B protein is 1,112 amino acids in length. Comparison of the human last exon (exon 16) sequence with orthologous sequences from chimpanzee, orangutan, rhesus macaque, mouse, and chicken reveals the human-specific GAG to TAG mutation at the codon 1,113 ( Fig. 1e; Supplementary Fig. S8 ). If the stop codon is reverted to the ancestral sequence, the human PDE3B gene would encode a protein with 1,117 amino acids. Interestingly, the chimpanzee PDE3B gene also exhibits a species-specific nonsense mutation at the codon 1,114 (CGA to TGA). All WGS clone sequences currently available supports this mutation in chimpanzee, rejecting a chance of sequencing error in the genome assembly. The biochemical and physiological effect of these species-specific mutations remains to be determined. SERPINA13: serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13
The serpin genes encode serine proteinase inhibitors involved in diverse biological functions (Silverman et al. 2001) . The human SERPINA13 (also known as kallistatin-like or KAL-like) is a member of the serpin cluster at the chromosome band 14q32.13 where 11 serpin genes are found (Marsden and Fournier 2005) . The gene encodes a protein with 307 amino acids. It is composed of 5 exons with the stop codon in exon 4. Comparison of the exon 4 sequences of the gene from human, chimpanzee, orangutan, and rhesus macaque indicates that the stop codon is a result of human-specific mutation that might have been fixed in the human lineage after the human-chimpanzee divergence (Fig. 1f) . The predicted full-length chimpanzee SERP-INA13 is 394 amino acids in length and has a highly conserved amino acid sequence of clade A serpins ( Supplementary Fig. S9 ). The truncated human SERP-INA13 would not be functional at least as a proteinase inhibitor since it loses the active loop which is critical for the proteinase inhibition activity. The original biological function, which is presumably lost in humans, of the ancestral SERPINA13 is unknown. It might have been secreted from the liver because mRNA from this gene has been detected in human liver (Marsden and Fournier 2005) .
TAP2: transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
The transporter associated with antigen processing (TAP) is a heterodimer consisting of TAP1 and TAP2 and plays a pivotal role in antigen presentation by translocating processed peptides from cytosol into the endoplasmic reticulum . Many sequence polymorphisms have been reported for the human TAP2 gene, including a well-known stop codon polymorphism (CAG to TAG) at codon 687 (Colonna et al. 1992; Powis et al. 1992) . The dbSNP database record (accession no. rs241448) indicates that the stop codon allele is more frequent among humans: 0.812 (T) versus 0.188 (C). Sequence comparison reveals that all other great apes (chimpanzee, gorilla, and orangutan) have non-stop codon sequence CAG at this position ( Fig. 1g; Supplementary Fig. S10 ). It confirms that the stop codon allele arose in a human ancestor and was selected over the non-stop codon allele. To our knowledge, there has been no report of any selective advantage of the stop codon allele.
UIP1: 26S proteasome-associated UCH interacting protein 1
The human UIP1 protein interacts with ubiquitin carboxyl-terminal hydrolase L5 (UCHL5; also known as UCH37) (Li et al. 2001 ). Its precise role in the biological process is not known but it has been hypothesized that UIP1 may regulate the ubiquitinated protein turnover by hindering the association of UCHL5 with the 26S proteasome (Li et al. 2001) . We found two human-specific mutations of the ancestral coding sequence ( Fig. 1h ; Supplementary Fig. S11 ). One is the CAG-to-TAG mutation at codon 359 which leads to a premature termination compared with the ancestral protein of 371 amino acids in length. The other is the single adenine nucleotide deletion (TAG to TG) within codon 372, which would abolish the ancestral stop codon and induce out-of-frame translation through the entire 3¢ untranslated region if the preceding nonsense mutation did not happen.
ZNF277: zinc finger protein (C2H2 type) 277
ZNF277 is a C2H2 type zinc finger-containing protein which is highly conserved even in Caenorhabditis elegans ( Supplementary Fig. S12 ) (Liang et al. 2000) . Comparison of the exon 12 sequences from human, chimpanzee, orangutan, rhesus macaque, and mouse reveals that the human ZNF277 has a nonsense mutation at codon 439 (CAA to TAA) (Fig. 1i) . The mutation leads to production of six amino acid-less polypeptide in human cells compared with chimpanzee ZNF277 (444 amino acids). The human ZNF277 is predicted to contain 5 C2H2 type zinc fingers and a 30 amino acid coiled coil domain which are preserved in all orthologous proteins. These domains are known to mediate DNA binding and protein-protein interaction, respectively, suggesting that ZNF277 might be a transcriptional regulator. It is probable that the six-residue truncation may not deter the protein from functioning in human cells particularly because the C-terminus is less conserved compared with other parts. However, given that ZNF277 might be a transcriptional regulator, the slight modification of the protein could result in a significant alteration of downstream gene expression.
Discussion
Destructive change such as frameshift and nonsense mutation in a coding sequence of a gene usually results in a genetic disease caused by the production of malfunctioning protein or by the loss of the gene product (Caputi et al. 2002; Kang et al. 1997) . However, a substantial number of genes that had been modified by frameshift or nonsense mutation specifically in human lineage have been reported (Angata et al. 2004; Chou et al. 2002; Dolphin et al. 1998; Hahn and Lee 2005; Hamann et al. 2003; Stedman et al. 2004; Winter et al. 2001) . Furthermore, a couple of the gene inactivation cases have been proposed to play some role in the development of human-specific traits (Chou et al. 2002; Stedman et al. 2004 ). These observations indicate that some destructive mutations can be tolerated or even be constructive for evolution of species-specific phenotypes (Olson 1999) . In this study, we present nine evolutionarily conserved genes that acquired stop codon mutation in the human genome. The phenotypic effects of most of these truncated gene products are unclear and yet to be examined. These nonsense mutations, together with previously reported human-specific frameshift mutations (Hahn and Lee 2005) , provide additional opportunities for studying the effect of genetic alterations that distinguish humans from chimpanzees.
Of the nine cases reported here, the gene is probably inactivated in three due to the loss of the active site (Table 2 ). These are CML2, which is a genomic duplicate of NAT8, and MT1L and SERPINA13, which are members of the metallothionein and the clade A serpin clusters of genes, respectively. Lineage-specific pseudogenization of some members of gene clusters harboring functionally overlapping genes is rather common. For example, humans have much higher fraction of olfactory receptor pseudogenes compared with apes (Gilad et al. 2003) . However, in the case of the CML2, MT1L, and SERPINA13 genes, we cannot rule out the possibility that these genes had a dosage-dependent or isogene-specific function, which became lost in humans.
Each of the six other genes with a nonsense mutation reported in the present study appears to produce a functional protein since the mutation results in a loss of only a small number of amino acid residues from its C-terminus ( Table 2 ). The number of amino acids removed ranges from 2 (NPPA) to 17 (TAP2). Although the change is small, the effect could be large. For example, the human atrial natriuretic peptide (ANP) encoded by the NPPA gene is shorter by only two amino acids compared with the ancestral form: The mature human and chimpanzee peptides are 28 and 30 amino acids, respectively, in length ( Supplementary Fig. S7 ). The stop codon mutation of the NPPA gene is polymorphic, allowing a direct comparison of the physiological influence of the two peptides with different lengths. The ancestral CGA codon allele that produces a 30 amino acid-long ANP has been reported to show a significant association with cardiovascular diseases compared with the human-specific stop codon allele, which is more prevalent in human populations (Gruchala et al. 2003; Rubattu et al. 2004) . It is interesting that the shorter ANP is advantageous in humans because all known ANP peptides in other organisms have the additional two arginines at their C-termini. It is not known why other organisms do not suffer from the harmful effect of the longer isoform as humans do.
Five genes described in the present study are known or predicted to show a stop codon polymorphism in humans (Table 2) : CML2, FLJ14640, MT1L, NPPA, and TAP2. Allele frequencies reported in dbSNP database and sequence count data from genomic, mRNA, WGS, and EST clones indicate that the stop codon allele is more prevalent than the ancestral non-stop codon allele in each case (Fig. 1) . The stop codon allele must have arisen in a certain human ancestor and must have been spreading across human individuals. The stop codon allele appears to be approaching fixation in the human population, although it is also possible that the polymorphisms are maintained by balancing natural selection. There are emerging examples of very recently arisen genetic changes that are being positively selected in local populations in response to biological, environmental, or cultural influences (Balter 2005) . Even some stop codon mutations that lead to a functional gene loss exhibit beneficial effect on the individual carrying the mutant allele. For example, the stop codon polymorphism of Toll-like receptor 5 (TLR5) is associated with protection from the development of systemic lupus erythematosus (Hawn et al. 2005 ).
We present 10 nonsense mutations in 9 genes in this study (see Fig. 1 ). Eight of these are C:G to T:A transitions (7 C to T and 1 G to A) and two are C:G to A:T transversions (1 C to A and 1 G to T). The substitution pattern agrees well with the observation that hydrolytic deamination of cytosine generating uracil is the major cause of single nucleotide change (Pearl 2000) . Of the eight C:G to T:A transitions, two are associated with CG to TG mutation and four are CAG to TAG mutation, suggesting that the methylation-mediated deamination of 5-methylcytosine of CpG dinucleotide and CpNpG trinucleotide may be responsible for these mutations (Clark et al. 1995; Krawczak et al. 1998 ).
In the present study, we identified ancestral genes on the basis of protein sequence homology to distantly related species. The existence of the distant homologs makes it likely that the gene has been conserved through a long period of evolution and therefore must play an important role in an essential biological process, which might be specifically modified in human lineage. Genome sequencing of orangutan, rhesus, and other primates are currently under way. For this study, we used orangutan and/or rhesus macaque WGS trace data for verification of the final candidates. When high-quality and high-coverage genome sequences become available, one can directly compare these genomes to find human-specific genetic alterations without the supporting evidence from the distantly related species.
